+

WO2003008599A3 - System zur erzeugung klonaler oder komplexer populationen rekombinanter adenoviren und deren anwendung - Google Patents

System zur erzeugung klonaler oder komplexer populationen rekombinanter adenoviren und deren anwendung Download PDF

Info

Publication number
WO2003008599A3
WO2003008599A3 PCT/EP2002/008024 EP0208024W WO03008599A3 WO 2003008599 A3 WO2003008599 A3 WO 2003008599A3 EP 0208024 W EP0208024 W EP 0208024W WO 03008599 A3 WO03008599 A3 WO 03008599A3
Authority
WO
WIPO (PCT)
Prior art keywords
site
specific recombinase
application
recombinant adenoviruses
producing
Prior art date
Application number
PCT/EP2002/008024
Other languages
English (en)
French (fr)
Other versions
WO2003008599A2 (de
Inventor
Moritz Hillgenberg
Original Assignee
Develogen Ag
Moritz Hillgenberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Develogen Ag, Moritz Hillgenberg filed Critical Develogen Ag
Priority to EP02764728A priority Critical patent/EP1409700A2/de
Priority to US10/483,962 priority patent/US20050123898A1/en
Publication of WO2003008599A2 publication Critical patent/WO2003008599A2/de
Publication of WO2003008599A3 publication Critical patent/WO2003008599A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die Erfindung betrifft ein neuartiges System zur Herstellung rekombinanter Adenoviren (rAd); Einsatzgebiete sind die Medizin, Veterinärmedizin, Biotechnologie, Gentechnik und die funktionelle Genomanalyse. Das erfindungsgemässe System zur rAd-Herstellung besteht bevorzugt aus - einem Donorvirus, dessen Verpackungssignal (i) partiell deletiert ist und (ii) von parallel orientierten Erkennungsstellen für eine ortsspezifische Rekombinase umrahmt wird, - einer Verpackungszelllinie, die die ortsspezifische Rekombinase exprimiert und Donorplasmiden, die (i) eine oder zwei Erkennungsstellen für die ortspezifische Rekombinase, (ii) das vollständige virale Verpackungssignal, (iii) gegebenenfalls zwei Erkennungsstellen für eine selten schneidende Restriktionsendonuklease und (iv) insertionsstellen für Fremd-DNA bzw. insertierte Fremd-DNA enthalten.
PCT/EP2002/008024 2001-07-18 2002-07-18 System zur erzeugung klonaler oder komplexer populationen rekombinanter adenoviren und deren anwendung WO2003008599A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP02764728A EP1409700A2 (de) 2001-07-18 2002-07-18 System zur erzeugung klonaler oder komplexer populationen rekombinanter adenoviren und deren anwendung
US10/483,962 US20050123898A1 (en) 2001-07-18 2002-07-18 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01117379 2001-07-18
EP01117379.6 2001-07-18

Publications (2)

Publication Number Publication Date
WO2003008599A2 WO2003008599A2 (de) 2003-01-30
WO2003008599A3 true WO2003008599A3 (de) 2003-09-18

Family

ID=8178066

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/008024 WO2003008599A2 (de) 2001-07-18 2002-07-18 System zur erzeugung klonaler oder komplexer populationen rekombinanter adenoviren und deren anwendung

Country Status (3)

Country Link
US (1) US20050123898A1 (de)
EP (1) EP1409700A2 (de)
WO (1) WO2003008599A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427816A4 (de) * 2001-09-18 2004-12-01 Clontech Lab Inc Auf stellenspezifischer rekombinase beruhendes verfahren zur herstellung von adenovirusvektoren
US8709778B2 (en) * 2008-10-28 2014-04-29 Xavier Danthinne Method of adenoviral vector synthesis
EP2776071B1 (de) * 2011-11-09 2018-08-08 Cedars-Sinai Medical Center Transkriptionsfaktor-basierte erzeugung von herzschrittmacherzellen und verwendungsverfahren dafür
FR3040845B1 (fr) 2015-09-04 2018-05-18 Schneider Electric Industries Sas Methode d'adressage automatique dans une architecture de communication ethernet
CN108048483B (zh) * 2018-01-30 2021-02-02 中国疾病预防控制中心病毒病预防控制所 复制型重组腺病毒HAdV-5载体系统及其应用
CN112468320A (zh) * 2020-11-09 2021-03-09 江苏方天电力技术有限公司 一种基于新型智能融合终端的自动拓扑识别方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999041400A1 (en) * 1998-02-17 1999-08-19 Genzyme Corporation Methods for pseudoadenoviral vector production

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2319497A (en) * 1996-03-07 1997-09-22 Regents Of The University Of California, The Helper-free, totally defective adenovirus for gene therapy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999041400A1 (en) * 1998-02-17 1999-08-19 Genzyme Corporation Methods for pseudoadenoviral vector production

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HARDY S ET AL: "CONSTRUCTION OF ADENOVIRUS VECTORS THROUGH CRE-LOX RECOMBINATION", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 71, no. 3, 1 March 1997 (1997-03-01), pages 1842 - 1849, XP000670223, ISSN: 0022-538X *
HILLGENBERG M ET AL: "System for efficient helper-dependent minimal adenovirus construction and rescue.", HUMAN GENE THERAPY. UNITED STATES 10 APR 2001, vol. 12, no. 6, 10 April 2001 (2001-04-10), pages 643 - 657, XP009002050, ISSN: 1043-0342 *
PARKS R J ET AL: "A HELPER.DEPENDENT ADENOVIRUS VECTOR SYSTEM: REMOVAL OF HELPER VIRUS BY CRE-MEDIATED EXCISION OF THE VIRAL PACKAGING SIGNAL", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 24, 26 November 1996 (1996-11-26), pages 13565 - 13570, XP000617948, ISSN: 0027-8424 *
TASHIRO F ET AL: "CONSTRUCTING ADENOVIRAL VECTORS BY USING THE CIRCULAR FORM OF THE ADENOVIRAL GENOME CLONED IN A COSMID AND THE CRE-LOXP RECOMBINATIONSYSTEM", HUMAN GENE THERAPY, XX, XX, vol. 10, no. 11, 20 July 1999 (1999-07-20), pages 1845 - 1852, XP000946594, ISSN: 1043-0342 *

Also Published As

Publication number Publication date
US20050123898A1 (en) 2005-06-09
WO2003008599A2 (de) 2003-01-30
EP1409700A2 (de) 2004-04-21

Similar Documents

Publication Publication Date Title
Perez et al. Mutants of the Rous sarcoma virus envelope glycoprotein that lack the transmembrane anchor and cytoplasmic domains: analysis of intracellular transport and assembly into virions
Au et al. Gene synthesis by a lcr-based approach: High-level production of leptin-l54 using synthetic gene inescherichia coli
CN107099850B (zh) 一种通过酶切基因组构建CRISPR/Cas9基因组敲除文库的方法
Kreppel et al. Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors
WO2001039797A3 (en) Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
WO1999020766A3 (en) NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
WO2003068923A3 (en) Signal for packaging of influenza virus vectors
JPH06261763A (ja) 修飾真核細胞質ｄｎａウイルス及びその産生方法
EP0752887A4 (de) Rekombinanter immunschwächepoxvirus
WO2002057447A2 (en) Methods and reagents for amplification and manipulation of vector and target nucleic acid sequences
WO2000077233A3 (en) Complement-resistant non-mammalian dna viruses and uses thereof
WO2003008599A3 (de) System zur erzeugung klonaler oder komplexer populationen rekombinanter adenoviren und deren anwendung
JP5103398B2 (ja) 両末端配列決定（ｐａｉｒｅｄｅｎｄｓｅｑｕｅｎｃｉｎｇ）
CN116179549A (zh) 通过5’utr序列变体修饰基因转录和翻译效率
UA48936C2 (uk) Спосіб одержання вірусу курячої анемії (cav) у дволанцюговій формі, рекомбінантна нуклеїнова кислота (варіанти), діагностичний набір (варіанти), вакцинний препарат (варіанти), культура клітин (варіанти), спосіб одержання діагностичного набору (варіанти)
CA2230925A1 (en) Fusion protein delivery system and uses thereof
WO2004090132A3 (en) Method for isolating nucleic acids
WO2001090340A3 (en) Assembly of large viral genomes and chromosomes from subclones
CN117165611A (zh) 一种构建mRNA体外转录模板的骨架
EP0854197A3 (de) Primern zum Nachweis von HIV-1
Collmer et al. Infectious RNA transcripts from cloned cDNAs of cucumber mosaic viral satellites
Rodrigues et al. Scaleable purification process for gene therapy retroviral vectors
Makrides Gene transfer and expression in mammalian cells
Hart et al. A replication-deficient HIV-1 DNA used for quantitation of the polymerase chain reaction (PCR)
WO1999057284A3 (en) Attenuated influenza viruses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003514915

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002764728

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002764728

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10483962

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002764728

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载